Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Warren

Showing results (11-20 of 256) with videos related to

Pageof 26
Sort By:
Dermatologic Clinics|November 22, 2014
Pharmacogenomics and the resulting impact on psoriasis therapiesAmy C Foulkes, Richard B Warren
Drugs in Context|April 27, 2019
Brodalumab in psoriasis: evidence to date and clinical potentialAmy C Foulkes, Richard B Warren
Dermatology and Therapy|March 18, 2019
The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the LiteratureDavid Rutkowski, Hector Chinoy, Richard B Warren
Seminars in Cutaneous Medicine and Surgery|May 1, 2010
The future of biological therapiesRichard B Warren, Christopher E M Griffiths
Expert Review of Clinical Immunology|December 31, 2013
Treating moderate to severe psoriasis - best use of biologicsMaeve Lynch, Brian Kirby, Richard B Warren
American Journal of Clinical Dermatology|March 1, 2016
Novel Oral Therapies for Psoriasis and Psoriatic ArthritisZenas Z N Yiu, Richard B Warren
Clinics in Dermatology|August 30, 2008
Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporineRichard B Warren, Christopher E M Griffiths
Expert Opinion on Investigational Drugs|January 3, 2017
The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasisZenas Z N Yiu, Richard B Warren
Immunotherapy|February 26, 2015
Efficacy and safety of emerging immunotherapies in psoriasisZenas Z N Yiu, Richard B Warren
Clinical Pharmacology and Therapeutics|July 13, 2017
Raising Standards for the Evaluation of Future Psoriasis Therapeutics: A Critical ChecklistZenas Z N Yiu, Richard B Warren
Pageof 26

Showing results (11-20 of 256) with videos related to

Sort By:
Pageof 26
Dermatologic Clinics|November 22, 2014
Pharmacogenomics and the resulting impact on psoriasis therapiesAmy C Foulkes, Richard B Warren
Drugs in Context|April 27, 2019
Brodalumab in psoriasis: evidence to date and clinical potentialAmy C Foulkes, Richard B Warren
Dermatology and Therapy|March 18, 2019
The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the LiteratureDavid Rutkowski, Hector Chinoy, Richard B Warren
Seminars in Cutaneous Medicine and Surgery|May 1, 2010
The future of biological therapiesRichard B Warren, Christopher E M Griffiths
Expert Review of Clinical Immunology|December 31, 2013
Treating moderate to severe psoriasis - best use of biologicsMaeve Lynch, Brian Kirby, Richard B Warren
American Journal of Clinical Dermatology|March 1, 2016
Novel Oral Therapies for Psoriasis and Psoriatic ArthritisZenas Z N Yiu, Richard B Warren
Clinics in Dermatology|August 30, 2008
Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporineRichard B Warren, Christopher E M Griffiths
Expert Opinion on Investigational Drugs|January 3, 2017
The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasisZenas Z N Yiu, Richard B Warren
Immunotherapy|February 26, 2015
Efficacy and safety of emerging immunotherapies in psoriasisZenas Z N Yiu, Richard B Warren
Clinical Pharmacology and Therapeutics|July 13, 2017
Raising Standards for the Evaluation of Future Psoriasis Therapeutics: A Critical ChecklistZenas Z N Yiu, Richard B Warren
Pageof 26